MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$959,000K
Net Income
$149,100K
Net Profit Margin
15.55%
EPS
$1.39
Unit: Thousand (K) dollars
Revenue Breakdown
INGREZZANet Product Sales
CRENESSITYNet Product Sales
VYKATXRNet Product Sales
Other Revenue Royalty Earnings
Revenue Breakdown
Product
Collaboration Revenue
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
959,000
814,500
805,500
794,900
Cost of revenues
-
13,800
17,600
14,000
Cost of revenues, excluding amortization of acquired intangible assets
23,200
-
-
-
Research and development
326,700
296,200
258,200
250,000
Acquired in-process research and development
1,500
21,200
17,000
300
Selling, general, and administrative
439,700
318,500
301,800
291,600
Amortization of acquired intangible assets
16,400
-
-
-
Gain on sale of business, net of transaction costs
0
28,600
-
-
Total operating expenses
807,500
621,100
594,600
555,900
Operating income
151,500
193,400
210,900
239,000
Interest expense
2,900
-
-
-
Unrealized loss (gain) on equity investments
1,200
25,300
2,700
30,600
Charges associated with convertible senior notes
-
-
0
0
Investment income and other, net
12,400
28,100
25,800
22,200
Total other income, net
10,700
53,400
28,500
52,800
Income before provision for income taxes
162,200
246,800
239,400
291,800
Provision for income taxes
17,800
48,900
85,700
82,300
Net income
144,400
197,900
153,700
209,500
Foreign currency translation adjustments, net of tax
-600
0
100
-1,600
Unrealized gain (loss) on available-for-sale debt securities, net of tax
4,100
-12,700
0
-900
Comprehensive income
149,100
185,200
153,600
210,200
Basic EPS
1.43
1.97
1.538
2.11
Diluted EPS
1.39
1.91
1.477
2.04
Basic Average Shares
101,000,000
100,500,000
99,900,000
99,400,000
Diluted Average Shares
104,200,000
103,400,000
104,000,000
102,500,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
INGREZZANet Product Sales
$716,500K
(14.75%↑ Y/Y)
CRENESSITYNet Product Sales
$183,500K
(244.92%↑ Y/Y)
VYKATXRNet Product Sales
$54,300K
Other Revenue Royalty
Earnings
$4,700K
Total revenues
$959,000K
(39.49%↑ Y/Y)
Investment income and
other, net
$12,400K
(-39.81%↓ Y/Y)
Unrealized loss (gain) on
equity investments
$1,200K
(117.91%↑ Y/Y)
Operating income
$151,500K
(4.05%↑ Y/Y)
Total other income,
net
$10,700K
(-23.02%↓ Y/Y)
Total operating
expenses
$807,500K
(49.01%↑ Y/Y)
Interest expense
$2,900K
Income before
provision for income taxes
$162,200K
(1.69%↑ Y/Y)
Selling, general, and
administrative
$439,700K
(53.58%↑ Y/Y)
Research and development
$326,700K
(33.73%↑ Y/Y)
Cost of revenues,
excluding amortization of...
$23,200K
Amortization of acquired
intangible assets
$16,400K
Acquired in-process
research and development
$1,500K
Net income
$144,400K
(34.33%↑ Y/Y)
Unrealized gain (loss) on
available-for-sale debt...
$4,100K
(51.85%↑ Y/Y)
Foreign currency
translation adjustments,...
-$600K
(25.00%↑ Y/Y)
Provision for income taxes
$17,800K
(-65.77%↓ Y/Y)
Comprehensive income
$149,100K
(34.32%↑ Y/Y)
Buy us a coffee
NEUROCRINE BIOSCIENCES INC (NBIX)
NEUROCRINE BIOSCIENCES INC (NBIX)